ITTO20040760A1 - Uso di un corticosteroide in associazione ad altri principi attivi per il trattamento della stenosi vascolare e la prevenzione della restenosi vascolare - Google Patents
Uso di un corticosteroide in associazione ad altri principi attivi per il trattamento della stenosi vascolare e la prevenzione della restenosi vascolareInfo
- Publication number
- ITTO20040760A1 ITTO20040760A1 IT000760A ITTO20040760A ITTO20040760A1 IT TO20040760 A1 ITTO20040760 A1 IT TO20040760A1 IT 000760 A IT000760 A IT 000760A IT TO20040760 A ITTO20040760 A IT TO20040760A IT TO20040760 A1 ITTO20040760 A1 IT TO20040760A1
- Authority
- IT
- Italy
- Prior art keywords
- vascular
- corticosteroid
- association
- prevention
- treatment
- Prior art date
Links
- 206010057469 Vascular stenosis Diseases 0.000 title 1
- 239000003246 corticosteroid Substances 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 208000037803 restenosis Diseases 0.000 title 1
- 230000002792 vascular Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000760A ITTO20040760A1 (it) | 2004-11-03 | 2004-11-03 | Uso di un corticosteroide in associazione ad altri principi attivi per il trattamento della stenosi vascolare e la prevenzione della restenosi vascolare |
| CA002586212A CA2586212A1 (en) | 2004-11-03 | 2005-11-02 | Use of a corticosteroid in association with a diuretic and an antacid for the treatment of vascular stenosis and the prevention of vascular restenosis |
| EP05809315A EP1814557A1 (en) | 2004-11-03 | 2005-11-02 | Use of a corticosteroid in association with a diuretic and an antacid for the treatment of vascular stenosis and the prevention of vascular restenosis |
| PCT/IB2005/003271 WO2006048736A1 (en) | 2004-11-03 | 2005-11-02 | Use of a corticosteroid in association with a diuretic and an antacid for the treatment of vascular stenosis and the prevention of vascular restenosis |
| BRPI0517983-1A BRPI0517983A (pt) | 2004-11-03 | 2005-11-02 | uso de corticosteróide em associação com diurético e antiácido para tratamento de estenose vascular e prevenção de reestenose vascular |
| RU2007120522/14A RU2007120522A (ru) | 2004-11-03 | 2005-11-02 | Использование кортикостероида в сочетании с диуретиком и антацидом для лечения стеноза сосудов и предупреждения рестеноза сосудов |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000760A ITTO20040760A1 (it) | 2004-11-03 | 2004-11-03 | Uso di un corticosteroide in associazione ad altri principi attivi per il trattamento della stenosi vascolare e la prevenzione della restenosi vascolare |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ITTO20040760A1 true ITTO20040760A1 (it) | 2005-02-03 |
Family
ID=36051437
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT000760A ITTO20040760A1 (it) | 2004-11-03 | 2004-11-03 | Uso di un corticosteroide in associazione ad altri principi attivi per il trattamento della stenosi vascolare e la prevenzione della restenosi vascolare |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1814557A1 (it) |
| BR (1) | BRPI0517983A (it) |
| CA (1) | CA2586212A1 (it) |
| IT (1) | ITTO20040760A1 (it) |
| RU (1) | RU2007120522A (it) |
| WO (1) | WO2006048736A1 (it) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8324192B2 (en) | 2005-11-12 | 2012-12-04 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
| US8679545B2 (en) | 2005-11-12 | 2014-03-25 | The Regents Of The University Of California | Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract |
| US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
| LT3354276T (lt) | 2007-11-13 | 2020-04-27 | Meritage Pharma, Inc. | Kompozicijos, skirtos skrandžio ir žarnyno uždegimo gydymui |
| US20090143343A1 (en) | 2007-11-13 | 2009-06-04 | Meritage Pharma, Inc. | Compositions for the treatment of inflammation of the gastrointestinal tract |
| EP2127639A1 (en) * | 2008-05-26 | 2009-12-02 | Universiteit Utrecht Holding B.V. | Corticosteroid containing liposomes for treatment of cardiovascular diseases |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6500938B1 (en) * | 1998-01-30 | 2002-12-31 | Incyte Genomics, Inc. | Composition for the detection of signaling pathway gene expression |
| AR032316A1 (es) * | 2000-04-12 | 2003-11-05 | Novartis Ag | Uso de una composicion farmaceutica para la fabricacion de medicamentos y una composicion farmaceutica |
-
2004
- 2004-11-03 IT IT000760A patent/ITTO20040760A1/it unknown
-
2005
- 2005-11-02 EP EP05809315A patent/EP1814557A1/en not_active Withdrawn
- 2005-11-02 CA CA002586212A patent/CA2586212A1/en not_active Abandoned
- 2005-11-02 WO PCT/IB2005/003271 patent/WO2006048736A1/en not_active Ceased
- 2005-11-02 BR BRPI0517983-1A patent/BRPI0517983A/pt not_active Application Discontinuation
- 2005-11-02 RU RU2007120522/14A patent/RU2007120522A/ru not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006048736A1 (en) | 2006-05-11 |
| CA2586212A1 (en) | 2006-05-11 |
| RU2007120522A (ru) | 2008-12-10 |
| BRPI0517983A (pt) | 2008-10-21 |
| EP1814557A1 (en) | 2007-08-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1799154A4 (en) | STENT AND METHOD FOR PRODUCING THE STENT | |
| ZA200705113B (en) | Solid dosage form comprising proton pump inhibitor and suspension made thereof | |
| DK1150678T3 (da) | Anvendelse af 3-hydroxy-3-methylglutarylcoenzym A-reduktaseinhibitorer til fremstillingen af et medikament til behandlingen af diabetisk neuropati | |
| ZAA200501454S (en) | Chair bodies and chairs | |
| DE60238422D1 (de) | Optimierte dosierung bei paclitaxelhaltigen stents | |
| IL178012A0 (en) | Diphenyl-indol-2-on compounds and their use in the treatment of cancer | |
| ATE553096T1 (de) | Pyridazinderivate und ihre verwendung als therapeutische wirkstoffe | |
| CA112175S (en) | Dispenser | |
| CA113972S (en) | Track for display shelving | |
| DE602004029308D1 (de) | Stents und Stenteinbringungssysteme | |
| WO2006017822A3 (en) | Quinazoline derivatives and their use in the treatment of thrombocythemia | |
| ITTO20040760A1 (it) | Uso di un corticosteroide in associazione ad altri principi attivi per il trattamento della stenosi vascolare e la prevenzione della restenosi vascolare | |
| CA115335S (en) | Massage chair | |
| CA115333S (en) | Massage chair | |
| CA115337S (en) | Massage chair | |
| SI2340872T1 (sl) | Nove farmacevtske formulacije, uporabne v zdravljenju nespečnosti | |
| WO2006124477A3 (en) | Combination therapy with inhibitors of hmgb and caspase for the treatment of inflammatory diseases | |
| PT1865966E (pt) | Uso de fármacos anti-inflamatórios não esteróides por inalação no tratamento de bronquite aguda e crónica | |
| ITTO20040460A1 (it) | Prodotti igienico-sanitario assorbente indossabile a guisa di mutandina e relativo procedimento di fabbricazione. | |
| ITMO20040175A1 (it) | Dispositivo per l'introduzione ed il posizionamento di stent in vasi sangugni. | |
| NO20022747D0 (no) | Behandlingsstol | |
| FI20061130L (fi) | Tuberkuloosia hoitava ja ehkäisevä aine | |
| AU2003244437A1 (en) | Quinoxalinones and their use especially in the treatment of cardiovascular diseases | |
| ITRM20040008A1 (it) | Struttura di supporto e posizionamento di elementi modulari per assiemi per la realizzazione di figure complesse. | |
| ITVI20040243A1 (it) | Cassetto per mobili impiegati in strutture medico - chirurgiche |